FISH ALLERGY ANTIGEN

Inhibitors of the tissue factor-protease activated receptor 2 (TF-PAR2) signaling pathway for use in the treatment or prevention of heart failure (HF) and associated or resulting diseases

Stress test and treatment of chronic kidney disease

MATERIALS AND METHODS FOR DIAGNOSIS

USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES

GALECTIN-3 IMMUNOASSAY

SERUM PROTEIN BIOMARKER PANEL FOR IDIOPATHIC PULMONARY FIBROSIS

PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT

MARKERS FOR DIAGNOSING INFECTIONS

NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF

METHODS OF TREATING CANCER

ANTI-MICROBIAL PEPTIDE (AMP) SIGNATURES FOR DIAGNOSTICS, STRATIFICATION, AND TREATMENT OF MICROBIOME-ASSOCIATED DISEASE

BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS

Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof

THORACIC DUCT AS A SAMPLE COLLECTION RESERVOIR

BIOMARKER-BASED TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND DIABETIC KIDNEY DISEASE

Urinary Metabolites as Predictors of Acute Mountain Sickness Severity

METHODS OF USING MESOTHELIN

Highly Sensitive System and Method for Analysis of Troponin

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

BIOMARKER AND DRUG COMBINATIONS FOR HEART FAILURE PREDICTION

METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS

METHOD OF DIAGNOSING AND TREATING NONALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS

PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY

Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof

METHODS AND SYSTEMS FOR DETECTION AND DISCOVERY OF BIOMARKERS

GATA6-AS1 lncRNA FOR USE IN THERAPY

METHODS FOR TREATING INHERITED METABOLIC DISORDERS

METHOD FOR PREDICTING CAUSE-SPECIFIC THERAPEUTIC EFFECT OF SENSORINEURAL HEARING LOSS, AND DIAGNOSTIC KIT USED THEREFOR

METHODS OF IDENTIFYING THE PRESENCE AND/OR CONCENTRATION AND/OR AMOUNT OF PROTEINS OR PROTEOMES

DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION

DIAGNOSIS OF SEPSIS

METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE

CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER

Methods and Systems for Quantifying Lipoprotein(A) Using Candidate References

KIDNEY FUNCTION BIOMARKERS

METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS

METHOD FOR THE ASSESSMENT OF PERIMENOPAUSE OR MENOPAUSE STATUS VIA ANALYSIS OF THE IgG GLYCOME

METHODS OF MONITORING INFLAMMATORY BOWEL DISEASES

USE OF STROMAL CELL-DERIVED FACTOR 1 (SDF1) AS A BIOMARKER FOR DIAGNOSING AND TREATING SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure

PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS

IHH AS A BIOMARKER AND THERAPEUTIC TARGET FOR NONALCOHOLIC STEATOHEPATITIS (NASH)

METHODS AND COMPOSITIONS RELATED TO BCL2 AND BIM HETERODIMER ANTIBODIES

DIAGNOSIS AND TREATMENT FOR CHRONIC INFLAMMATION AND VIRUS INFECTION

Beta blocker therapy with electrical administration

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

METHODS FOR THE DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS

OPTIMAL COMBINATION OF EARLY BIOMARKERS FOR INFECTION AND SEPSIS DIAGNOSIS IN EMERGENCY DEPARTMENT

METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING AN ANEMIA AND/OR A METABOLIC CONDITION RELATED TO THE NUTRITIONAL STATE AND/OR FLUID BALANCE OF THE BLOOD

Kit comprising antibody binding acrolein-protein conjugate for diagnosing nephropathy

Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases

PSP94 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS

METHODS AND COMPOSITIONS FOR TREATMENT OF RENAL INJURY AND RENAL FAILURE

METHODS AND DESIGN OF LUNG HEALTH DIAGNOSTIC (LHDx) TECHNOLOGY FOR DIAGNOSIS AND PROGNOSIS-BASED INTERVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD), EMPHYSEMA AND AGE-RELATED LUNG DISEASES

MARKERS FOR PREDICTING CORONAVIRUS DISEASE 2019 (COVID-19) IMMUNE CHECKPOINT STORM, APPLICATION AND KIT THEREOF

NMR METHODS AND SYSTEMS FOR THE RAPID DETECTION OF BACTERIA

HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

CD47 BLOCKADE AND COMBINATION THERAPIES THEREOF FOR REDUCTION OF VASCULAR INFLAMMATION

COMPOSITION FOR CONTROLLED OVARIAN STIMULATION

IN VITRO METHOD FOR PREDICTING THE RISK OF DEVELOPING A BREAST LATE EFFECT AFTER RADIOTHERAPY

Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19

Device and method for detection of analytes

ASSAYS AND METHODS FOR THE DIAGNOSIS OF POST-STREPTOCOCCAL DISORDERS

SYSTEM AND METHOD FOR COLLECTION AND DISSEMINATION OF BIOLOGIC SAMPLE TEST RESULTS DATA

CIRCULATING miRNA AND PROTEIN BIOMARKERS FOR FACIOSCAPULOHUMERAL DYSTROPHY

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS

METHODS OF MONITORING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY BY MEASURING POLYMERISED AAT

METHODS FOR SYSTEMATICALLY ASSESSING LOCAL INFLAMMATION AND ACTIVE REPAIR

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PATIENTS WITH A HISTORY OF EARLY LIFE ADVERSITY

Assay method for the detection of VCAM-1 and alpha-2-macroglobulin in blood

MAGNETIC POINT-OF-CARE SYSTEMS AND ASSAYS FOR DETERMINING GFAP IN BIOLOGICAL SAMPLES

MARKER FOR ASSISTING IN DIAGNOSIS OF NEPHROTIC SYNDROME AND USE THEREOF

NICOTINAMIDE DINUCLEOTIDE (NAD) DETECTION AND QUANTIFICATION

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

METHOD FOR DIAGNOSING AMYLOID DISEASES

QUANTIFICATION OF SPERM CENTRIOLE QUALITY

METHODS FOR USE IN PREVENTATIVE HEALTHCARE

APPARATUS AND METHOD FOR DETECTING MISFOLDED PROTEIN IN BIOLOGICAL SAMPLE

POLYOL BIOMARKERS FOR CONGENITAL DISORDERS OF GLYCOSYLATION

METHOD FOR PREDICTING PATIENT RESPONSE TO CD40-TARGETED THERAPIES

METHODS OF DIAGNOSTIC OF LIVER FIBROSIS

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ITCH

TREATMENT OF CASTLEMAN DISEASE

EGG ALLERGY ANTIGEN

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

LIPID BIOMARKERS FOR STABLE AND UNSTABLE HEART DISEASE

METHOD FOR SCREENING A SUBJECT FOR THE RISK OF CHRONIC KIDNEY DISEASE

HEALTH TEST FOR A BROAD SPECTRUM OF HEALTH PROBLEMS

MARKERS AND METHODS FOR DIAGNOSING HEATSTROKE

DIAGNOSTICS OF PERIODONTITIS

METHOD FOR PROGNOSIS

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION

METHODS FOR DECREASING MORTALITY RISK AND IMPROVING HEALTH

USE OF KLK5 ANTAGONISTS FOR THE TREATMENT OF A DISEASE

COMPOSITIONS, METHODS AND KITS FOR TREATING COMPLEMENT RELATED DISORDERS

USE OF MALIC ENZYME 2 IN PREPARATION OF DIAGNOSTIC REAGENT OR MEDICAMENT FOR SILICOSIS OR PULMONARY FIBROSIS-RELATED DISEASE

Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK

MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS

NANOBODIES WITH SPECIFIC AFFINITY FOR VOLTAGE GATED SODIUM CHANNELS

COMPOSITION FOR REGULATING OSTEOCLAST DIFFERENTIATION, AND USE THEREOF

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CROHN'S DISEASE

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY

METHOD FOR ASSESSING THE SEVERITY OF SARS

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING MICROPARTICLE-ASSOCIATED DISEASES AND CONDITIONS

METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MENTAL AND/OR A BEHAVIOURAL DISORDER

METHODS AND ALGORITHMS FOR AIDING IN THE DETECTION OF CANCER

DIAGNOSTICS OF GINGIVITIS

KITS, REAGENTS AND METHODS FOR THE ASSESSMENT OF LIVER DISEASES

METHODS FOR IDENTIFYING AND TREATING ANTIBODY-MEDIATED ACQUIRED PRIMARY OR RECURRENT IDIOPATHIC NEPHROTIC SYNDROME

Cardiovascular Event Risk Prediction

TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE

NOVEL BIOMARKER OF ACUTE CORONARY SYNDROMES

FOCAL ADHESION COMPLEX PROTEINS AS A DIAGNOSTIC MARKER FOR PODOCYTOPHATHIES

Method for Correction for Sample Volume

COMPLEMENTOME ASSAY

Application of microbiological markers in non-invasive identification/early warning of fatty liver in perinatal cows

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES

PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY

GDF3 AS BIOMARKER AND BIOTARGET IN POST-ISCHEMIC CARDIAC REMODELING

Protein Damage in Aging and Age-Related Diseases

Dissolved Protein Arthritis Markers

EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT

Serum metabolic biomarkers for detecting tuberculosis and tuberculosis detection kit

METHODS AND MATERIALS FOR ASSESSING AND TREATING OBESITY

DIAGNOSTIC METHODS FOR LIVER DISORDERS

DIAGNOSTIC METHODS FOR KAWASAKI DISEASE

INFLAMMATORY CYTOKINES AND FATIGUE IN SUBJECT WITH A COMPLEMENT MEDIATED DISEASE

METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING FIBROSIS

ASSESSMENT OF INTESTINAL BARRIER FUNCTION TO IMPROVE TREATMENT OF INFLAMMATORY BOWEL DISEASE

H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

METHODS AND SYSTEMS FOR DETECTING TISSUE CONDITIONS

Diagnostic methods for cardiovascular diseases

KYNURENINE: USEFUL BIOMARKER IN ACUTE COVID-19 AND LONG COVID

MARKERS TO DISCRIMINATE SARCOIDOSIS FROM HEALTHY CONTROLS, TUBERCULOSIS AND LUNG CANCERS

Compositions and methods for capturing exosomes

Method to identify, isolate and quantify a biomarker for the degradation of the lysosomal alpha-glucosidase, GAA, and to detect and isolate related glycosylated proteinsin vitro and in vivo

A Newborn Metabolic Vulnerability Model For Identifying Preterm Infants At Risk Of Adverse Outcomes, And Uses Thereof

KIT FOR DETECTING ANTI-VINCULIN-IMMUNOGLOBULIN G (IgG) ANTIBODY

METHOD FOR DIAGNOSING STROKE UTILIZING GENE EXPRESSION SIGNATURES

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A DYSTONIA

NOVEL USE OF HIC-5 INHIBITOR

LSD DOSE IDENTIFICATION

METHODS AND SYSTEMS FOR STRATIFYING INFLAMMATORY BOWEL DISEASE PATIENTS

DIAGNOSIS OF STAGE B2 DMVD

Methods of treating patients at risk for renal injury and renal failure

METHODS AND KITS OF ASSESSING STATUS, RISK OR PROGNOSIS OF TYPE 1 DIABETES

TTP phosphorylation for the identification of personalized medicines

COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS, CONTAINING TRIAZOLE DERIVATIVE AS ACTIVE INGREDIENT

Method and system for rapid prediction offast blood glucose level in pregnant subjects

METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS

Methods of Identifying Schizophrenia Patients At Risk for Relapse

COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME RELATED DISEASES OR CONDITIONS

CXCL14 AS PREDICTIVE BIOMARKER FOR ACUTE LIVER FAILURE AND DEATH

METHOD FOR NASH RISK ASSESSMENT

GDF-15 FOR PREDICTING THE DISEASE SEVERITY OF A PATIENT WITH COVID-19

Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan disease

REGULATORY B CELLS AND THEIR USES

ALLERGY ANTIGEN AND EPITOPE FOR SAME

USE OF MICRO-RNA TO IMPROVE AND TREAT CHRONIC PHASE CARDIAC FUNCTION

METHOD FOR DETECTING INFLAMMATION-RELATED PLATELET ACTIVATION

Saposin-A derived peptides and uses thereof

YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS

APPLICATION OF THBS1 PROTEIN AND THBS3 PROTEIN AS BIOMARKERS FOR DETECTING ACUTE MYOCARDIAL INFARCTION

PANEL OF INFLAMMASOME PROTEINS AS RADIATION BIODOSIMETER

PREDICTION AND EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY

Measurement, Diagnosis, Treatment and Management of Metabolic Syndrome

SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA

Nanoparticles and distinct exosome subsets for detection and treatment of cancer

A METHOD FOR DISTINGUISHING HEALTHY INDIVIDUALS FROM INDIVIDUALS HAVING INFECTIOUS OR INFLAMMATORY CONDITIONS

Assay for Assessing Heart Failure

PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING

BIOLOGICAL VESICLES ISOLATION AND DISCOVERY METHODS AND SYSTEMS

ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS

PTX3 AS PROGNOSTIC MARKER IN COVID-19

METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS

Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy

ASSESSING THE RESPONSE TO TREATMENT OF SINUSITIS

BIOFLUID-BASED PROTEIN AND MIRNA BIOMARKERS FOR NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY

SYSTEM AND METHOD FOR BIOMARKER ANALYSIS IN SPORTING, WELLNESS AND HEALTHCARE

METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE

METHOD FOR DETERMINING WHETHER A SUBJECT HAS A DISEASE OR CONDITION OR IS AT RISK OF DEVELOPING A DISEASE OR CONDITION

METHOD FOR ENRICHING EXOSOMES

Identifying Risk of Cerebra Edema

Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing

Treatment of severe community acquired pneumonia

Markers for determining the biological age of a dog

RAMAN TESTING SYSTEM AND METHODS OF DETECTING PATHOGENS

Biomarkers for identifying e-cigarette, or vaping, product use-associated lung injury

PREDICTING A SEPSIS CONDITION

METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS

NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS

Thyroglobulin quantitation by mass spectrometry

METHOD OF DIAGNOSIS OF INFECTION BY THE SARS-COV-2 VIRUS

SARS-COV-2 INFECTION RISK ASSESSMENT METHOD

Compositions and methods for the removal of biofilms

COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION

METHOD OF ASSISTING DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE

DETECTION OF SARS-COV-2 PROTEINS AND MITOCHONDRIAL PROTEINS IN PLASMA NEURON-DERIVED EXTRACELLULAR VESICLES AND ASTROCYTE-DERIVED EXTRACELLULAR VESICLES

SERUM BIOMARKERS FOR PREDICTING AND PREVENTING HEMORRHAGIC STROKE

METHODS AND ASSOCIATED USES, KITS AND SYSTEM FOR ASSESSING SEPSIS

METHOD FOR THE DIAGNOSIS AND TREATMENT OF ESSENTIAL PRIMARY HYPERTENSION

DRY EYE DISEASE BIOMARKERS AND THEIR USE FOR TREATMENT

METHOD FOR TESTING AGGRAVATION RISK OF PERSON INFECTED WITH NOVEL CORONAVIRUS, TEST KIT THEREFOR, COMPANION DIAGNOSTIC DRUG AND AGGRAVATION RISK MARKER THEREOF

DIAGNOSTICS AND USE OF QUORUM SENSING MOLECULES IN MUSCLE WASTING

SITE- AND STRUCTURE-SPECIFIC CORE FUCOSYLATION IN LIVER DISEASE

ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS

COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS

METHOD FOR TREATING ASTHMA OR ALLERGIC DISEASE

ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOF

Treatment of circadian rhythm disorders

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE

DETECTING SEPSIS

PROFILING OF IMMUNODOMINANT PLA2R1 EPITOPES AS A PROGNOSIS AND PREDECTIVE FACTOR IN MEMBRANOUS NEPHROPATHY

TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS

Immune Cell Biomarkers of Cardiovascular Disease

MEASURING TRAIL BY LATERAL FLOW IMMUNOASSAY

BIOMARKERS FOR ASSESSING LIVER DISEASE

TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A NOVEL CIRCULATING HORMONE COMPLEX

USE OF BIOMARKER IN PREPARATION OF LUNG CANCER DETECTION REAGENT AND RELATED METHOD

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure

BIOMARKER IN BLOOD FOR MACULAR EDEMA AND USE THEREOF

STIMULATION OF THE HEALING PROCESS ON THE RETINAL PIGMENT EPITHELIUM AFTER R:GEN WITH RTF TECHNOLOGY

TREATMENT FOR VIRAL RESPIRATORY INFECTIONS

Methods for treating cholestasis

A SYNTHENTIC POLY-TRANSTHYRETIN AFFINITY TRAP FOR DETECTING AMYLOIDOGENIC TRANSTHYRETIN FORMS IN PLASMA SAMPLES OFTRANTHYRETIN AMYLOIDOSIS PATIENTS

Calprotectin Assay

Methods of Detecting and Treating Immune Responses Associated with Viral Infection

METHODS OF DETECTING CLOSTRIDIUM DIFFICILE INFECTIONS

METHOD OF DETECTING TB IN BLOOD SAMPLE

Devices, systems, and methods for measuring biomarkers in biological fluids

METHOD AND SYSTEM FOR DIAGNOSING CENTRAL NERVOUS SYSTEM DISEASE USING MULTIPLE BIOMARKERS IN PERIPHERAL BODY FLUID

BIOMARKERS FOR THE DIAGNOSIS OF RESPIRATORY TRACT INFECTIONS

Assays and methods for targeted treatment of hydrosalpinx

METHODS FOR DIFFERENTIATING DESTRUCTIVE THYROIDITIS FROM OTHER PATHOLOGICAL CONDITIONS

METHODS FOR USING PROTEIN BIOMARKERS IN IDIOPATHIC PULMONARY FIBROSIS

Methods For The Identification Of UBQLN2-Mediated Amyotrophic Lateral Sclerosis (ALS)

Method of Detecting Sepsis Using Primary and Secondary Hematology Parameters

INTESTINAL AND FECAL BIOMARKERS FOR INTESTINAL HEALTH OF POULTRY

PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD CHOLESTEROL, PREVENTING OR TREATING CARDIOVASCULAR DISEASES AND REDUCING INFLAMMATION

METHOD OF DIFFERENTIATING OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY, METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOP ATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY

Purified Enriched Population Exosomes Derived From Individuals With A Chronic Progressive Lung Disease For Noninvasive Detection, Staging, And Medical Monitoring Of Disease Progression

PROTEIN DIAGNOSTIC BIOMARKER FOR SEVERE DRUG ERUPTION

Markers for renal disease

ASSAY METHOD FOR THE DETECTION OF VCAM-1 AND ALPHA-2-MACROGLOBULIN IN BLOOD

METHOD OF SCREENING FOR A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY

Biomarker identification for imminent and/or impending heart failure

ASSESSING AND TREATING ACUTE DECOMPENSATED HEART FAILURE

METHOD FOR PREDICTING THE RISK OF INCIDENCE OF CHRONIC KIDNEY DISEASE

Compositions and Methods for Identifying and Treating Dystonia Disorders

ANTIBODY FOR DETECTING ACETYLATION OF COX2 PROTEIN, AND USES THEREOF

Composition for preventing or treating keloids or hypertrophic scars

COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE

Method for analyzing glycosaminoglycan

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

GASTRO-RETENTIVE DRUG DELIVERY SYSTEM

Means and Method for Detecting Aberrant Erythroblasts

ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE

Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis

ASSAY AND KIT FOR LIVE ANTIGEN DETECTION AND MONITORING OF NEUROCYSTICERCOSIS

Biomarkers For Endometriosis

C5aR INHIBITOR REDUCTION OF URINARY sCD163

METHODS FOR IDENTIFYING PATTERNS OF IFN INDUCED EXPRESSION AND USE IN DIAGNOSIS, MONITORING AND THERAPY

DETECTION OF SYMMETRICAL DIMETHYLARGININE

METHODS FOR DETECTING FOOD ALLERGIES

Endometriosis Biomarkers

Leucine-Rich Repeat Kinase 2 Allosteric Modulators

METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS

SYSTEM FOR DETERMINING AN UNDERLYING CAUSE OF ANEMIA

METHOD FOR PREVENTING, TREATING OR DELAYING HEART FAILURE BY USING NEUREGULIN, AND COMPOSITION

SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME

MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME

METHOD FOR ASSESSING RISK OF CUTANEOUS ADVERSE DRUG REACTIONS CAUSED BY EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS, DETECTION KIT THEREOF, AND USE THEREOF

METHODS AND KITS FOR CHARACTERIZING AND IDENTIFYING AUTISM SPECTRUM DISORDER

Anti-FcRn Antibodies

BAG3 AS A TARGET FOR THERAPY OF HEART FAILURE

Noninvasive method to quantify kidney function and functional decline

Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof

INHIBITION OF AUTISM SPECTRUM DISORDER USING DECOY ANTIGENS TO MATERNAL BRAIN-REACTIVE ANTIBODIES

ANTIBODIES AGAINST N-ACETYLGLUCOSAMINE AND N-ACETYL-GALACTOSAMINE

TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION

Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients

NOVEL PATHOLOGICAL MARKER AND USES THEREOF

NEW PROTEIN MARKERS OF RENAL DAMAGE

SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID

Identification of Unique Blood-Based Gene Expression Profiles in Children with Regressive Autism Spectrum Disorder (ASD) and Ileocolitis

The Kinase NEK10 and Its Use in Treating and Diagnosing Bronchiectasis and Other Respiratory Disorders

DETECTING GUT BARRIER DYSFUNCTION AND/OR CIRRHOSIS

CIRCULATING NEDD9 IS INCREASED IN PULMONARY ARTERIAL HYPERTENSION

ANTI-IDE ANTIBODIES AND USES OF SAME

AUTOANTIBODIES AS BIOMARKERS FOR AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 1

Composition for treating or diagnosing osteoarthritis targeting ACVR2B

BIOMARKERS FOR PREDICTING INTENSIVE CARE UNIT STAY DURATION FOR MECHANICALLY VENTILATED COVID-19 PATIENTS

COMPOUNDS AND METHODS FOR THE DETECTION OF FABRY DISEASE

Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure